One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?.
Booth, Christopher M. MD 1,; Berry, Scott R. MD 1,
doi : 10.1200/JCO.21.01972
Volume 39(34) pgs. 3767-3886 December 1, 2021
Pathway to Precision Patient-Reported Outcomes.
Kaufmann, Tara L. MD, MSCE 1; Rocque, Gabrielle B. MD, MSPH 2,,3,,
doi : 10.1200/JCO.21.02163
Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma.
Hall, William A. MD 1,2,; Dawson, Laura A. MD 3,; Hong, Theodore S. MD 4,; Palta, Manisha MD 5,; Herman, Joseph M. MD, MSc, MSHCM 6,; Evans, Douglas B. MD 2; Tsai, Susan MD, MHS 2; Ferrone, Cristina R. MD 7; B. Fleming, Jason MD 8,; Chang, Daniel T. MD 9,; Crane, Christopher MD 10,; Koong, Albert C. MD 11,; Oar, Andrew MD 12; Parikh, Parag MD 13,; Erickson, Beth MD 1,2,; Hoffe, Sarah MD 8,; Goodman, Karyn A. MD, MS 14,,
doi : 10.1200/JCO.21.01220
SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities.
Johnston, Emily E. MD, MS 1,2,; Martinez, Isaac BA 1; Davis, Elizabeth S. BA, MS 1; Caudill, Caroline BA 1; Richman, Joshua MD, PhD 1,3; Brackett, Julienne MD 4,; Dickens, David S. MD 5; Kahn, Alissa MD 6; Schwalm, Carla MD 7; Sharma, Archana DO 8; Patel, Pratik A. MD 9; Bhatia, Smita MD, MPH 1,2,; Levine, Jennifer M. MD, MSW 10,; Wolfson, Julie A. MD, MSHS 1,2; on behalf of the POCC Consortium
doi : 10.1200/JCO.21.00702
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.
Kanemitsu, Yukihide MD 1,,; Shimizu, Yasuhiro MD, PhD 2; Mizusawa, Junki ME 1,; Inaba, Yoshitaka MD, PhD 2; Hamaguchi, Tetsuya MD, PhD 3,; Shida, Dai MD, PhD 1; Ohue, Masayuki MD, PhD 4,; Komori, Koji MD, PhD 2; Shiomi, Akio MD 5; Shiozawa, Manabu MD, PhD 6; Watanabe, Jun MD, PhD 7,; Suto, Takeshi MD 8; Kinugasa, Yusuke MD, PhD 9,; Takii, Yasumasa MD 10; Bando, Hiroyuki MD, PhD 11; Kobatake, Takaya MD 12,; Inomata, Masafumi MD, PhD 13; Shimada, Yasuhiro MD 14,; Katayama, Hiroshi MD 1; Fukuda, Haruhiko MD 1,; on behalf of the JCOG Colorectal Cancer Study Group
doi : 10.1200/JCO.21.01032
Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35.
Henry, N. Lynn MD, PhD 1,,; Kim, Sungjin MS 2; Hays, Ron D. PhD 3; Diniz, Marcio A. PhD 2; Luu, Michael MPH 2; Cecchini, Reena S. PhD 4; Yothers, Greg PhD 4,; Rogatko, Andre PhD 2; Ganz, Patricia A. MD 5,
doi : 10.1200/JCO.21.00910
Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children.
Keilty, Dana MDCM, MSc 1; Khandwala, Mohammad MD 1; Liu, Zhihui Amy PhD 2; Papaioannou, Vicky MCISc 3; Bouffet, Eric MD 4,; Hodgson, David MD, MPH 1; Yee, Ryan BMSc 1; Cushing, Sharon MD, MSc 5,; Laperriere, Normand MD 1; Ahmed, Sameera MSc 1; Mabbott, Donald PhD 6; Ramaswamy, Vijay MD, PhD 4,; Tabori, Uri MD, PhD 4; Huang, Annie MD, PhD 4; Bartels, Ute MD 4; Tsang, Derek S. MD, MSc 1,
doi : 10.1200/JCO.21.00899
Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
Sabnis, Himalee S. MD, MSc 1,2,,; Shulman, David S. MD 3; Mizukawa, Benjamin MD 4,5; Bouvier, Nancy BS 6; Zehir, Ahmet PhD 7,; Fangusaro, Jason MD 1,2,; Fabrizio, Vanessa A. MD, MS 6; Whitlow, Chanta MPA 1; Winchester, Marilyn BS 6; Agresta, Laura MD 4,5; Turpin, Brian DO 4,5; Wechsler, Daniel S. MD, PhD 1,2; DuBois, Steven G. MD, MS 3,; Glade-Bender, Julia MD 6,; Castellino, Sharon M. MD, MSc 1,2,; Shukla, Neerav MD 6,
doi : 10.1200/JCO.21.01213
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.
Andtbacka, Robert H. I. MD, CM 1,,; Curti, Brendan MD 2,; Daniels, Gregory A. MD, PhD 3,; Hallmeyer, Sigrun MD 4,; Whitman, Eric D. MD 5,; Lutzky, Jose MD 6,; Spitler, Lynn E. MD 7,; Zhou, Karl PhD 8; Bommareddy, Praveen K. MS, PhD 9,; Grose, Mark BSc 10,; Wang, Meihua PhD 11,; Wu, Cai PhD 11,; Kaufman, Howard L. MD 12,
doi : 10.1200/JCO.20.03246
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
Maas, Sybren L. N. MD, PhD 1,2; Stichel, Damian PhD 1; Hielscher, Thomas MSc 3; Sievers, Philipp MD 1; Berghoff, Anna S. MD, PhD 4,5; Schrimpf, Daniel PhD 1; Sill, Martin PhD 6; Euskirchen, Philipp MD 7; Blume, Christina MSc 1; Patel, Areeba MSc 1; Dogan, Helin BSc 1; Reuss, David MD 1; Dohmen, Hildegard MD 8; Stein, Marco MD 8,9; Reinhardt, Annekathrin MD 1; Suwala, Abigail K. MD 1; Wefers, Annika K. MD 1; Baumgarten, Peter MD 10; Ricklefs, Franz MD 11; Rushing, Elisabeth J. MD 12,; Bewerunge-Hudler, Melanie PhD 13; Ketter, Ralf MD 14; Schittenhelm, Jens MD 15; Jaunmuktane, Zane MD 16,17; Leu, Severina MD 18; Greenway, Fay E. A. MD 19; Bridges, Leslie R. MD 20; Jones, Timothy MD 19; Grady, Conor MD 21; Serrano, Jonathan MSc 21; Golfinos, John MD 21; Sen, Chandra MD 21; Mawrin, Christian MD 22; Jungk, Christine MD 23; Hanggi, Daniel MD 24; Westphal, Manfred MD 11; Lamszus, Katrin MD 11; Etminan, Nima MD 25; Jungwirth, Gerhard MD, PhD 23; Herold-Mende, Christel PhD 26; Unterberg, Andreas MD 23; Harter, Patrick N. MD 27,28; Wirsching, Hans-Georg MD 29; Neidert, Marian C. MD 30; Ratliff, Miriam MD 25; Platten, Michael MD 31; Snuderl, Matija MD 32; Aldape, Kenneth D. MD 33; Brandner, Sebastian MD 16,34; Hench, Jurgen MD 18; Frank, Stephan MD 18; Pfister, Stefan M. MD 6,35,36,; Jones, David T. W. PhD 6,37; Reifenberger, Guido MD 38,39; Acker, Till MD 8; Wick, Wolfgang MD 40,41; Weller, Michael MD 29,; Preusser, Matthias MD 5,; von Deimling, Andreas MD 1,; Sahm, Felix MD, PhD 1,6,,; For the German Consortium on Aggressive Meningiomas (KAM)
doi : 10.1200/JCO.21.00784
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study.
Wierda, William G. MD, PhD 1,,; Allan, John N. MD 2,; Siddiqi, Tanya MD 3,; Kipps, Thomas J. MD, PhD 4,; Opat, Stephen MBBS 5,; Tedeschi, Alessandra MD 6,; Badoux, Xavier C. MBBS 7,; Kuss, Bryone J. MBBS, PhD 8,; Jackson, Sharon MD 9,; Moreno, Carol MD, PhD 10,; Jacobs, Ryan MD 11,; Pagel, John M. MD, PhD 12,; Flinn, Ian MD, PhD 13,; Pak, Yvonne PhD 14,; Zhou, Cathy MS 14,; Szafer-Glusman, Edith PhD 14,; Ninomoto, Joi PharmD 14,; Dean, James P. MD, PhD 14,; James, Danelle F. MD, MAS 14,; Ghia, Paolo MD, PhD 15,; Tam, Constantine S. MBBS, MD 16,
doi : 10.1200/JCO.21.00807
A Validated Risk Prediction Model for Breast Cancer in US Black Women.
Palmer, Julie R. ScD 1,2,; Zirpoli, Gary PhD 1; Bertrand, Kimberly A. ScD 1,2; Battaglia, Tracy MD 2,; Bernstein, Leslie PhD 3; Ambrosone, Christine B. PhD 4; Bandera, Elisa V. PhD 5,; Troester, Melissa A. PhD 6; Rosenberg, Lynn ScD 1; Pfeiffer, Ruth M. PhD 7; Trinquart, Ludovic PhD 8
doi : 10.1200/JCO.21.01236
Reflections on Fellowship Training for Community-Based Practice.
Roberts, Daniel A. MD 1,
doi : 10.1200/JCO.21.01413
Interactions Between Dose and Volume in Chemoradiotherapy of Esophageal Cancer.
Pottgen, Christoph MD, PhD; Nestle, Ursula MD, PhD; Hocht, Stefan MD, PhD; Stuschke, Martin MD, PhD
doi : 10.1200/JCO.21.01579
Dose Escalation or Not-Does Age Matter?.
Lin, Yun-Hsuan MD; Huang, Shih-Yu MD; Chou, Shang-Yu MD; Huang, Tzu-Ting MD; Wang, Yu-Ming MD
doi : 10.1200/JCO.21.01706
Reply to C. Pottgen et al and Y.-H. Lin et al.
Hulshof, Maarten C. C. M. PhD, MD; van Laarhoven, Hanneke W. M. PhD, MD; on behalf of the ARTDECO study group
doi : 10.1200/JCO.21.01980
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer.
Mo, Dun-Chang MD; Qin, Lang MD; Ye, Lin-Jing MD
doi : 10.1200/JCO.21.01528
Reply to D.-C. Mo et al.
Kang, Yoon-Koo MD, PhD; Kim, Hyung-Don MD, PhD; Ryu, Min-Hee MD; Noh, Sung Hoon MD
doi : 10.1200/JCO.21.02043
